OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
Dasatinib Dosing & DREAMseq
20 minutes
Posted Dec 2, 2021 at 2:48 pm.
0:00
20:25
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Lots of updates to discuss from dasatinib dosing to ICI/TKI sequencing in BRAF-mutated metastatic melanoma to adjuvant chemo in node (+) breast cancer to some FDA approval updates.
Previous
Sun's Out, T Cells Out
Next
So, You Want to be a Pediatric Oncology Pharmacist
← See all 273 episodes of OncoPharm